Literature DB >> 32345058

A Review of Medicinal Plants in Cardiovascular Disorders: Benefits and Risks.

Muhammad Naveed1, Fatima Majeed2, Abdoh Taleb1, Hafiz Muhammad Zubair3, Muhammad Shumzaid4, Muhammad Asim Farooq5, Mirza Muhammad Faran Ashraf Baig6, Muhammad Abbas7, Muhammad Saeed8, Li Changxing9.   

Abstract

Many cultivated and wild plants are used for the management of various diseases, specifically renal and hepatic diseases and those of the immune and cardiovascular systems. In China, medicinal plants from ancient to modern history have been used in patients with angina pectoris, congestive heart failure (CHF), systolic hypertension, arrhythmia, and venous insufficiency for centuries. The latest increase in the fame of natural products and alternative medicine has revived interest in conventional remedies that have been consumed in the management of CVD. The cardio-protective properties of the various herbs are possibly due to their anti-oxidative, antihypercholesterolemic, anti-ischemic activities, and inhibition of platelet aggregation that reduce the risk of CVD. Ethno-pharmacological and biological properties of these plants are explored, based upon published scientific literature. Although a majority of medicinal plants having a biological mechanism that linked with CVD management, to date, published literature pertaining to their promising scientific properties are still poorly understood. Compared with synthetic medicines, alternative medicines do not need scientific studies before their formal approval from the government sector and due to this purpose; their safety, as well as efficacy, still remain elusive. Taken together, we addressed all accessible evidence on alternative medicines commonly consumed in CVD management. Our comprehensive analysis of the scientific literature indicated that many TCMs are available and valuable herbal medication would be the best alternative for the management of CVD as a complementary therapy. Furthermore, practitioners should always discuss possible benefits-risks of alternative medicines with patients so that they are aware of the consumption of alternative medications.

Entities:  

Keywords:  Cardiovascular Disease; Herb-Drug Interactions; Herbal Education; Herbal Medication; Herbal Modes of Action; Herbal Regulation; Patient Counseling; Phytochemicals; Side Effects

Year:  2020        PMID: 32345058     DOI: 10.1142/S0192415X20500147

Source DB:  PubMed          Journal:  Am J Chin Med        ISSN: 0192-415X            Impact factor:   4.667


  3 in total

1.  Molecular docking analysis of arjunolic acid from Terminalia arjuna with a coronary artery disease target APOE4.

Authors:  Lima Hazarika; Supriyo Sen; Jitesh Doshi
Journal:  Bioinformation       Date:  2021-11-30

Review 2.  Coronavirus Disease 2019 and Herbal Therapy: Pertinent Issues Relating to Toxicity and Standardization of Phytopharmaceuticals.

Authors:  Kayode Komolafe; Titilope Ruth Komolafe; Toluwase Hezekiah Fatoki; Afolabi Clement Akinmoladun; Bartholomew I C Brai; Mary Tolulope Olaleye; Afolabi Akintunde Akindahunsi
Journal:  Rev Bras Farmacogn       Date:  2021-03-11       Impact factor: 2.464

Review 3.  Zimbro (Juniperus communis L.) as a Promising Source of Bioactive Compounds and Biomedical Activities: A Review on Recent Trends.

Authors:  Ana C Gonçalves; José David Flores-Félix; Paula Coutinho; Gilberto Alves; Luís R Silva
Journal:  Int J Mol Sci       Date:  2022-03-16       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.